Results 351 to 360 of about 466,412 (376)

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Javier Cortés, Giuseppe Curigliano, Paolo Tarantino   +2 more
exaly  

Autoantibodies(AT) to neurotransmitters in patients with multiple sclerosis (MS)

Journal of the Neurological Sciences, 2021
Tatiana Vdovushkina, Sergey V. Makarov
openaire   +2 more sources

An overview of precision oncology basket and umbrella trials for clinicians

Ca-A Cancer Journal for Clinicians, 2020
Edward J Mills, Jay J H Park, Kristian Thorlund   +2 more
exaly  

Multiple Sclerosis (MS)

2017
Jacob Eitel, Aaron Kamer, Aaron Cohen-Gadol   +2 more
openaire   +1 more source

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi, Federico Gago
exaly  

Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine

Ca-A Cancer Journal for Clinicians, 2020
Adriana C Gamboa, Alessandro Gronchi, Kenneth Cardona   +2 more
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2018
Timothy R Church, Christopher R Flowers, Carmen E Guerra   +2 more
exaly  

Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy

Ca-A Cancer Journal for Clinicians, 2020
Kassandra I Alcaraz, K Robin Yabroff, Carmen E Guerra   +2 more
exaly  

P22-5 Multiple sclerosis (MS)

Clinical Neurophysiology, 2010
openaire   +2 more sources